WuXi Biologics (Cayman) logo
WuXi Biologics (Cayman)
WXXWY | OTC
Chart Builder DCF Calculator
$11.68
-$0.29 (-2.42%)
At close: Nov 16, 2026, 3:59 PM ET
$11.68
$0.00 (0.00%)
After-hours: Nov 16, 2026, 3:46 PM ET

WuXi Biologics (Cayman) Company Profile

Company profile explained

Company Profile

WuXi Biologics (Cayman) Inc. delivers integrated solutions covering the entire lifecycle of biological drug development, from initial discovery to full-scale manufacturing. These services are provided to clients worldwide, with a significant presence in China, North America, and Europe. Beyond its core offerings, the company engages in various specialized activities, including offering expert advice on biopharmaceutical technology, managing international sales agreements, and developing and providing advanced testing solutions. It also handles sales and marketing efforts, supports clinical trials and production of biologics, produces and distributes medical goods, operates a contract development and manufacturing organization (CDMO) for vaccines, and supplies essential materials to the industry. Founded in 2014, WuXi Biologics is based in Wuxi, China, and maintains strategic alliances with partners such as ImmuneOncia Therapeutics, Legochem Biosciences Inc, Worg Pharma, OncoC4, and Exelixis Inc.

Key Executives

Name Position
Jian Dong Chief Executive Officer of WuXi Vaccines
Zhisheng Chen Chief Executive Officer & Executive Director
Lihua Yu Chief Operating Officer & Senior Vice President
Ming Tu Chief Financial Officer & Executive Vice President
Angus Scott Marshall Turner Senior Vice President and Head of Global BD & Alliance Management
Ge Li Founder & Chairman
He Wang General Counsel, Chief Compliance Officer, SVP and Head of Legal & Compliance Department
Jijie Gu Chief Scientific Officer & President of Global Biologics Research
Lina Fan Senior Vice President & Head of Investor Relations
Xiaohui Liu Executive VP & Chief Human Resources Officer
Xuejun Gu CTO, Chief Client Officer, EVP of Global Biologics Development Department & Executive Director
WuXi Biologics (Cayman)
WuXi Biologics (Cayman) logo
Country China
IPO Date Dec 18, 2017
Industry Biotechnology
Sector Healthcare
Employees 13,252
CEO Zhisheng Chen

Contact Details

No. 108, Meiliang Road Wuxi, JS 214092 China

Stock Details

Ticker Symbol WXXWY
Exchange OTC
Fiscal Year n/a
Reporting Currency USD
CIK Code n/a
CUSIP Number 98260N108
ISIN Number US98260N1081
SIC Code n/a

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.